Literature DB >> 16537196

Use of simulated intestinal fluids with Caco-2 cells and rat ileum.

N Patel1, B Forbes, S Eskola, J Murray.   

Abstract

In most in vitro studies of oral drug permeability, little attempt is made to reproduce the gastrointestinal lumenal environment. The aim of this study was to evaluate the compatibility of simulated intestinal fluid (SIF) solutions with Caco-2 cell monolayers and Ussing chamber-mounted rat ileum under standard permeability experiment protocols. In preliminary experiments, fasted-state simulated intestinal fluid (FaSSIF) and fed-state simulated intestinal fluid (FeSSIF) solutions based on the dissolution medium formulae of Dressman and co-workers (1998) were modified for compatibility with Caco-2 cells to produce FaS-SIF and FeSSIF "transport" solutions for use with in vitro permeability models. For Caco-2 cells exposed to FaSSIF and FESSIF transport solutions, the transepithelial electrical resistance was maintained for over 4 h and mannitol permeability was equivalent to that in control (Hank's Balanced Salt Solution-treated) cell layers. Scanning electron microscopy revealed that microvilli generally maintained a normal distribution, although some shortening of microvilli and occasional small areas of denudation were observed. For rat ileum in the Ussing chambers, the potential difference (PD) collapsed to zero over 120 min when exposed to the FaSSIF transport solution and an even faster collapse of the PD was observed when the FeSSIF transport solution was used. Electron micrographs revealed erosion of the villi tips and substantial denudation of the microvilli after exposure of ileal tissue to FaSSIF and FeSSIF solutions, and permeability to mannitol was increased by almost two-fold. This study indicated that FaSSIF and FeSSIF transport solutions can be used with Caco-2 monolayers to evaluate drug permeability, but rat ileum in Ussing chambers is adversely affected by these solutions. Metoprolol permeability in Caco-2 experiments was reduced by 33% using the FaSSIF and 75% using the FeSSIF compared to permeability measured using HBSS. This illustrates that using physiological solutions can influence permeability measurements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537196     DOI: 10.1080/03639040500465991

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  9 in total

Review 1.  In vitro and in vivo models for the study of oral delivery of nanoparticles.

Authors:  Jennifer M Gamboa; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2013-02-13       Impact factor: 15.470

2.  Optimisation of the caco-2 permeability assay using experimental design methodology.

Authors:  Mark Lakeram; David J Lockley; Ruth Pendlington; Ben Forbes
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

3.  In vitro and ex vivo investigation of the impact of luminal lipid phases on passive permeability of lipophilic small molecules using PAMPA.

Authors:  Constantinos Markopoulos; Georgios Imanidis; Maria Vertzoni; Mira Symillides; Neil Parrott; Christos Reppas
Journal:  Pharm Res       Date:  2013-07-27       Impact factor: 4.200

4.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury.

Authors:  Mandy B Esch; Gretchen J Mahler; Tracy Stokol; Michael L Shuler
Journal:  Lab Chip       Date:  2014-08-21       Impact factor: 6.799

Review 5.  Nanomedicine for increasing the oral bioavailability of cancer treatments.

Authors:  Alessandro Parodi; Polina Buzaeva; Daria Nigovora; Alexey Baldin; Dmitry Kostyushev; Vladimir Chulanov; Lyudmila V Savvateeva; Andrey A Zamyatnin
Journal:  J Nanobiotechnology       Date:  2021-10-30       Impact factor: 10.435

6.  Characterizing the Physicochemical Properties of Two Weakly Basic Drugs and the Precipitates Obtained from Biorelevant Media.

Authors:  Miao Zhang; Bin Wu; Shudong Zhang; Lin Wang; Qin Hu; Dongyang Liu; Xijing Chen
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

Review 7.  Nanoparticle modification in biological media: implications for oral nanomedicines.

Authors:  Vishnaka Muraleetharan; Julia Mantaj; Magda Swedrowska; Driton Vllasaliu
Journal:  RSC Adv       Date:  2019-12-06       Impact factor: 4.036

8.  Multifunctional Bioreactor System for Human Intestine Tissues.

Authors:  Wenda Zhou; Ying Chen; Terrence Roh; Yinan Lin; Shengjie Ling; Siwei Zhao; James D Lin; Noor Khalil; Dana M Cairns; Eleana Manousiouthakis; Megan Tse; David L Kaplan
Journal:  ACS Biomater Sci Eng       Date:  2017-12-08

9.  A Biocompatible Synthetic Lung Fluid Based on Human Respiratory Tract Lining Fluid Composition.

Authors:  Abhinav Kumar; Wachirun Terakosolphan; Mireille Hassoun; Kalliopi-Kelli Vandera; Astrid Novicky; Richard Harvey; Paul G Royall; Elif Melis Bicer; Jonny Eriksson; Katarina Edwards; Dirk Valkenborg; Inge Nelissen; Dave Hassall; Ian S Mudway; Ben Forbes
Journal:  Pharm Res       Date:  2017-05-30       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.